Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2026)
Twist Bioscience (TWST) reported Cash from Investing Activities of -$12.7 million for Q1 2026, down 791.02% year-over-year from $1.8 million in Q1 2025, and down 27.92% quarter-over-quarter from -$9.9 million in Q4 2025.
Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Twist Bioscience (TWST) has 10 years of Cash from Investing Activities data on file, last reported at -$12.7 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$12.7 million, down 791.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$44.4 million (down 796.31% YoY), and the FY2025 annual result was -$24.8 million, down 706.32% from the prior year.
- Cash from Investing Activities slipped to -$12.7 million in Q1 2026 per TWST's latest filing, from -$9.9 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $41.2 million in Q1 2023 and troughed at -$13.3 million in Q1 2022.
- A 5-year average of -$365176.5 and a median of -$1.5 million in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities soared 409.61% in 2023, then sank 1221.66% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$7.0 million in 2022, then jumped by 159.75% to $4.2 million in 2023, then sank by 136.88% to -$1.5 million in 2024, then plunged by 546.68% to -$9.9 million in 2025, then retreated by 27.92% to -$12.7 million in 2026.
- Business Quant data shows TWST's Cash from Investing Activities at -$12.7 million in Q1 2026, -$9.9 million in Q4 2025, and -$12.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Twist Bioscience | 4.30 Bn | 4.30 Bn | 57.12 Mn | -12.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.71 Mn |
| Mar 31, 2026 | -12.71 Mn |
| Dec 31, 2025 | -9.93 Mn |
| Dec 31, 2025 | -9.93 Mn |
| Sep 30, 2025 | -12.40 Mn |
| Sep 30, 2025 | -12.40 Mn |
| Jun 30, 2025 | -9.40 Mn |
| Jun 30, 2025 | -9.40 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Dec 31, 2024 | -1.54 Mn |
| Sep 30, 2024 | -1.29 Mn |
| Sep 30, 2024 | -1.29 Mn |
| Jun 30, 2024 | -711,000.00 |
| Jun 30, 2024 | -711,000.00 |
| Mar 31, 2024 | -5.24 Mn |
| Mar 31, 2024 | -5.24 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Dec 31, 2023 | 4.17 Mn |